BIOMAT Database Logo BIOMAT Database Logo

Difference in cardiac uptake between 99mTc-HMDP and 99mTc-DPD for the non-invasive diagnosis of cardiac transthyretin amyloidosis. 2023

Matthieu Dietz, and Antoine Jobbé-Duval, and Caroline Moreau-Triby, and Anthime Flaus
Department of Nuclear Medicine, Cardiovascular Hospital Louis Pradel, Hospices Civils de Lyon, 59 Bvd Pinel, 69634, Lyon, France. matthieu.dietz@chu-lyon.fr.

UI MeSH Term Description Entries
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D011228 Prealbumin A tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver disease. Proalbumin,Transthyretin
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical
D028227 Amyloid Neuropathies, Familial Inherited disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. The different clinical types based on symptoms correspond to the presence of a variety of mutations in several different proteins including transthyretin (PREALBUMIN); APOLIPOPROTEIN A-I; and GELSOLIN. Familial Amyloid Polyneuropathies,Amyloid Neuropathy Type 1,Amyloid Polyneuropathy, British Type,Amyloid Polyneuropathy, Iowa Type,Amyloid Polyneuropathy, Swiss Type,Appalachian Type Familial Amyloid Polyneuropathy,British Type Amyloid Polyneuropathy,Cerebral Amyloid Angiopathy, British Type,Familial Amyloid Neuropathy, Andrade Type,Familial Amyloid Neuropathy, Finnish Type,Familial Amyloid Neuropathy, Portuguese Type,Familial Amyloid Polyneuropathy, Appalachian Type,Familial Amyloid Polyneuropathy, Jewish Type,Familial Amyloid Polyneuropathy, Type I,Familial Amyloid Polyneuropathy, Type II,Familial Amyloid Polyneuropathy, Type III,Familial Amyloid Polyneuropathy, Type IV,Familial Amyloid Polyneuropathy, Type V,Familial Amyloid Polyneuropathy, Type VI,Familial Portuguese Polyneuritic Amyloidosis,Finnish Type Familial Amyloid Neuropathy,Hereditary Neuropathic Amyloidosis,Iowa Type Amyloid Polyneuropathy,Jewish Type Familial Amyloid Polyneuropathy,Neuropathic Amyloid Syndrome,Polyneuritic Amyloidosis, Portuguese,Portuguese Polyneuritic Amyloidosis,Portuguese Type Familial Amyloid Neuropathy,Swiss Type Amyloid Polyneuropathy,Type I Familial Amyloid Polyneuropathy,Type II Familial Amyloid Polyneuropathy,Type III Familial Amyloid Polyneuropathy,Type IV Familial Amyloid Polyneuropathy,Type V Familial Amyloid Polyneuropathy,Type VI Familial Amyloid Polyneuropathy,Wohlwill-Andrade Syndrome,Wohlwill-Corino Andrade Syndrome,Amyloid Neuropathy, Familial,Amyloid Polyneuropathies, Familial,Amyloid Polyneuropathy, Familial,Amyloid Syndrome, Neuropathic,Amyloid Syndromes, Neuropathic,Amyloidoses, Hereditary Neuropathic,Amyloidoses, Portuguese Polyneuritic,Amyloidosis, Hereditary Neuropathic,Amyloidosis, Portuguese Polyneuritic,Familial Amyloid Neuropathies,Familial Amyloid Neuropathy,Familial Amyloid Polyneuropathy,Hereditary Neuropathic Amyloidoses,Neuropathic Amyloid Syndromes,Neuropathic Amyloidoses, Hereditary,Neuropathic Amyloidosis, Hereditary,Neuropathies, Familial Amyloid,Neuropathy, Familial Amyloid,Polyneuritic Amyloidoses, Portuguese,Polyneuropathies, Familial Amyloid,Polyneuropathy, Familial Amyloid,Portuguese Polyneuritic Amyloidoses,Wohlwill Andrade Syndrome,Wohlwill Corino Andrade Syndrome

Related Publications

Matthieu Dietz, and Antoine Jobbé-Duval, and Caroline Moreau-Triby, and Anthime Flaus
Tafamidis Decreases Cardiac Uptake of 99mTc-HMDP in Transthyretin Cardiac Amyloidosis.
December 2022, JACC. Cardiovascular imaging,
Matthieu Dietz, and Antoine Jobbé-Duval, and Caroline Moreau-Triby, and Anthime Flaus
Early-phase myocardial uptake intensity of 99mTc-HMDP vs 99mTc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis.
February 2018, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
Matthieu Dietz, and Antoine Jobbé-Duval, and Caroline Moreau-Triby, and Anthime Flaus
Quantitation of 99mTc-DPD uptake in patients with transthyretin-related cardiac amyloidosis.
September 2018, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis,
Matthieu Dietz, and Antoine Jobbé-Duval, and Caroline Moreau-Triby, and Anthime Flaus
99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
August 2012, Clinical nuclear medicine,
Matthieu Dietz, and Antoine Jobbé-Duval, and Caroline Moreau-Triby, and Anthime Flaus
Regression of Myocardial 99mTc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin Amyloidosis.
July 2023, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Matthieu Dietz, and Antoine Jobbé-Duval, and Caroline Moreau-Triby, and Anthime Flaus
Apical sparing pattern of left ventricular myocardial 99mTc-HMDP uptake in patients with transthyretin cardiac amyloidosis.
December 2018, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
Matthieu Dietz, and Antoine Jobbé-Duval, and Caroline Moreau-Triby, and Anthime Flaus
Optimizing 99mTc-DPD scintigraphy: Adding value to the diagnosis and treatment of cardiac transthyretin amyloidosis.
December 2021, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
Matthieu Dietz, and Antoine Jobbé-Duval, and Caroline Moreau-Triby, and Anthime Flaus
The role of serial 99mTc-DPD scintigraphy in monitoring cardiac transthyretin amyloidosis.
March 2022, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis,
Matthieu Dietz, and Antoine Jobbé-Duval, and Caroline Moreau-Triby, and Anthime Flaus
Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis.
February 2020, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
Matthieu Dietz, and Antoine Jobbé-Duval, and Caroline Moreau-Triby, and Anthime Flaus
Cardiac transthyretin amyloidosis 99mTc-DPD SPECT correlates with strain echocardiography and biomarkers.
June 2021, European journal of nuclear medicine and molecular imaging,
Copied contents to your clipboard!